These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3039766)
21. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency]. Fichna M; Gryczyńska M; Sowińska A; Sowiński J Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518 [TBL] [Abstract][Full Text] [Related]
22. Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests. Moreira AC; Martinez R; Castro M; Elias LL Clin Endocrinol (Oxf); 1992 Jun; 36(6):545-51. PubMed ID: 1330381 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin II increases ACTH release in the absence of endogenous arginine-vasopressin. Spinedi E; Negro-Vilar A Life Sci; 1984 Feb; 34(8):721-9. PubMed ID: 6321871 [TBL] [Abstract][Full Text] [Related]
24. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man. Hensen J; Hader O; Bähr V; Oelkers W J Clin Endocrinol Metab; 1988 Apr; 66(4):668-71. PubMed ID: 2831245 [TBL] [Abstract][Full Text] [Related]
25. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease. Berardelli R; Karamouzis I; D'Angelo V; Fussotto B; Minetto MA; Ghigo E; Giordano R; Arvat E J Endocrinol Invest; 2016 May; 39(5):537-42. PubMed ID: 26450146 [TBL] [Abstract][Full Text] [Related]
26. Management of hypertension and heart failure in patients with Addison's disease. Inder WJ; Meyer C; Hunt PJ Clin Endocrinol (Oxf); 2015 Jun; 82(6):789-92. PubMed ID: 25138826 [TBL] [Abstract][Full Text] [Related]
27. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure. Nicholls MG; Espiner EA; Donald RA J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213 [TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease. Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483 [TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin-aldosterone system of the normothermic marmot. Kastner PR; Zatzman ML; South FE; Johnson JA Am J Physiol; 1977 Jul; 233(1):R37-43. PubMed ID: 195479 [TBL] [Abstract][Full Text] [Related]
30. Plasma galanin, vasopressin, and oxytocin in patients with Addison's disease. Grenbäck E; Hulting AL; Bucht E; Petersson M Horm Metab Res; 2007 Aug; 39(8):589-95. PubMed ID: 17712724 [TBL] [Abstract][Full Text] [Related]
31. [Proceedings: Plasma renin activity in management of Addison's disease (author's transl)]. Linquette M; Lefebvre J; Fossati P; Fourlinnie JC; Cappoen JP; Lecieux P Ann Endocrinol (Paris); 1975; 36(2):103-4. PubMed ID: 1190719 [TBL] [Abstract][Full Text] [Related]
32. Addison's disease in pregnancy: Case report, management, and review of the literature. Margulies SL; Corrigan K; Bathgate S; Macri C J Neonatal Perinatal Med; 2020; 13(2):275-278. PubMed ID: 31744021 [TBL] [Abstract][Full Text] [Related]
33. Role of the renin-angiotensin system in the control of vasopressin and ACTH secretion during the development of renal hypertension in dogs. Ben LK; Maselli J; Keil LC; Reid IA Hypertension; 1984; 6(1):35-41. PubMed ID: 6319279 [TBL] [Abstract][Full Text] [Related]
34. Intra-cerebroventricular captopril reduces plasma ACTH and vasopressin responses to hemorrhagic stress. Cameron VA; Espiner EA; Nicholls MG; MacFarlane MR; Sadler WA Life Sci; 1986 Feb; 38(6):553-9. PubMed ID: 3003485 [TBL] [Abstract][Full Text] [Related]
35. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles. Ekman B; Blomgren J; Andersson PO; Carlsson M; Arnqvist HJ Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018 [TBL] [Abstract][Full Text] [Related]
36. Dose effect of adrenocorticotropin on aldosterone and cortisol biosynthesis in cultured bovine adrenal glomerulosa cells: in vitro correlate of hyperreninemic hypoaldosteronism. Braley LM; Adler GK; Mortensen RM; Conlin PR; Chen R; Hallahan J; Menachery AI; Williams GH Endocrinology; 1992 Jul; 131(1):187-94. PubMed ID: 1319318 [TBL] [Abstract][Full Text] [Related]
37. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system. Watanabe T; Oki Y; Orth DN Endocrinology; 1989 Oct; 125(4):1921-31. PubMed ID: 2551632 [TBL] [Abstract][Full Text] [Related]
38. Stress hormones in blood and cerebrospinal fluid of conscious sheep: effect of hemorrhage. Cameron V; Espiner EA; Nicholls MG; Donald RA; MacFarlane MR Endocrinology; 1985 Apr; 116(4):1460-5. PubMed ID: 2982587 [TBL] [Abstract][Full Text] [Related]
39. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency. Flad TM; Conway JD; Cunningham SK; McKenna TJ Clin Endocrinol (Oxf); 1996 Nov; 45(5):529-34. PubMed ID: 8977748 [TBL] [Abstract][Full Text] [Related]
40. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin. Spinedi E; Negro-Vilar A Neuroendocrinology; 1983 Dec; 37(6):446-53. PubMed ID: 6318148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]